Vaccination Against Pneumococcus in West Africa: Perspectives and Prospects

This article, published in the International Journal of General Medicine, provides epidemiological insights into pneumococcal conjugate vaccines in West Africa based on the prevailing pneumococcal serotypes in the subregion. The study covered pneumococcal isolates from Burkina Faso, Ghana, Nigeria, Mali, Senegal, and The Gambia. Based on the findings, researchers concluded that pneumococcal serotypes 1 and 5 were the most important serotypes responsible for pneumococcal disease in the region.

Follow the VRL

Free access to journal articles for users in the developing world

Some resources in the VRL require a subscription to view the full text. The World Health Organization’s (WHO) Health InterNetwork Access to Research Initiative (HINARI) provides free or very low cost online access to the major journals in biomedical and related social sciences to local, not-for-profit institutions in developing countries.